Estrogen- and tamoxifen-associated effects on brain structure and function

  title={Estrogen- and tamoxifen-associated effects on brain structure and function},
  author={J. L. Eberling and Christine C. Wu and Regina Tong-Turnbeaugh and William J. Jagust},

Figures and Tables from this paper

Cognitive effects of Tamoxifen in pre-menopausal women with breast cancer compared to healthy controls

The results of this exploratory study suggest that at least in pre-menopausal women, TAM may exert a widespread negative influence on cognitive abilities.

Multimodal MRI examination of structural and functional brain changes in older women with breast cancer in the first year of antiestrogen hormonal therapy

Increased brain activation during working memory processing may be a sign of functional compensation for treatment-related structural changes in older women with breast cancer, and this hypothesis should be tested in larger samples over longer time periods.

Postmenopausal hormone therapy and regional brain volumes

Conjugated equine estrogens with or without MPA are associated with greater brain atrophy among women aged 65 years and older; however, the adverse effects are most evident in women experiencing cognitive deficits before initiating hormone therapy.

Selective sparing of brain tissue in postmenopausal women receiving hormone replacement therapy

The Working Memory and Dorsolateral Prefrontal-Hippocampal Functional Connectivity Changes in Long-Term Survival Breast Cancer Patients Treated with Tamoxifen

It is demonstrated that the prefrontal cortex and hippocampus may be affected by tamoxifen treatment, supporting an antagonistic role of tamoxIFen in the long-term treatment of breast cancer patients.

Tamoxifen Improves Cholinergically Modulated Cognitive Performance in Postmenopausal Women

Evidence is provided that TMX may act as an estrogen-like agonist to enhance cholinergic system activity and hippocampally mediated learning to affect cognitive performance in older women using a model of anticholinergic drug-induced cognitive dysfunction.

Effects of estrogen therapy on age-related differences in gray matter concentration

It is suggested that initiation of ET around the time of menopause may modulate age-related differences in regional gray matter concentration and the functional significance of the findings remains unknown.

Ovarian steroids and their influence on hippocampal memory function and morphology

Present results underscore the variety of hormonal effects on the human memory system and their sensitivity to experimental factors and suggest that at least a part of the inconsistency in human literature can be accounted by not differeniating between hippocampus-dependent and -independent memory functions.

Early initiation of hormone therapy in menopausal women is associated with increased hippocampal and posterior cingulate cholinergic activity.

A differential effect of postmenopausal ET and EPT on cholinergic neuronal integrity was identified in post menopausal women and the findings are consistent with a preservation of cholinesterase neuronal integrity in the EPT group.



The effects of tamoxifen and estrogen on brain metabolism in elderly women.

The reduced concentrations of MI in the brains of women treated with tamoxifen and HRT, compared with those of control women, suggest that tamoxIFen has an effect similar to that of estrogen.

Effects of Estrogen Replacement Therapy on PET Cerebral Blood Flow and Neuropsychological Performance

Findings confirm the previous observation of the beneficial effects of ERT on figural memory and suggest an area for future research to examine mechanisms through which ERT may influence memory and other cognitive abilities.

Preliminary evidence that estrogen protects against age-related hippocampal atrophy

Estrogen use and brain metabolic change in older adults. A preliminary report

Estrogen and cerebral blood flow: a mechanism to explain the impact of estrogen on the incidence and treatment of Alzheimer's disease.

  • R. Greene
  • Medicine
    International journal of fertility and women's medicine
  • 2000
CBF is diminished in hypoestrogenic women, with regional patterns resembling those of patients with mild to moderate AD, and ERT reversed these detrimental blood flow changes back to a normal pattern after only 6 weeks of CEE therapy.

High-dose estradiol improves cognition for women with AD

Although these findings provide further clinical evidence to support a cognitive benefit of estrogen for women with AD, studies evaluating the effect of estradiol administration, in particular, using larger sample sizes and for longer treatment durations are warranted before the therapeutic potential of estrogen replacement for Women with AD can be firmly established.

Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.

The results suggest that estrogen in a therapeutic dosage alters brain activation patterns in postmenopausal women in specific brain regions during the performance of the sorts of memory function that are called upon frequently during any given day.

Estrogen, tamoxifen, and the brain.

The authors suggested that patients may have received neuroprotective benefits from tamoxifen and HRT, as evidenced by the lowered MI concentrations in their brains, which are highly speculative to interpret as indicative of neuroprotection.

Effect of Estrogen on Brain Activation Patterns in Postmenopausal Women During Working Memory Tasks

The results suggest that estrogen affects brain organization for memory in postmenopausal women in specific brain regions during the performance of the sorts of memory function that are called upon frequently during any given day.